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To investigate how neuronal activity in the prefrontal cortex changes in an animal model of schizophrenia, we recorded single
unit activity in the medial prefrontal cortex of urethane-anesthetized and awake rats following methamphetamine (MA) admin-
istration. Systemic MA injection (4mg/kg, IP) induced inconsistent changes, that is, both enhancement and reduction, in unit
discharge rate, with a subset of neurons transiently (<30min) elevating their activities. The direction of ﬁring rate change was
poorly predicted by the mean ﬁring rate or the degree of burst ﬁring during the baseline period. Also, simultaneously recorded
units showed opposite directions of ﬁring rate change, indicating that recording location is a poor predictor of the direction of
ﬁringratechange.TheseresultsraisethepossibilitythatsystemicMAinjectioninducesrandombidirectionalchangesinprefrontal
cortical unit activity, which may underlie some of MA-induced psychotic symptoms.
Copyright © 2007 Jinhwa Jang et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Several lines of evidence indicate the involvement of the pre-
frontal cortex (PFC) in the pathophysiology of schizophre-
nia. Postmortem and brain imaging studies revealed struc-
tural abnormalities in the PFC of schizophrenic patients [1–
7], and brain imaging studies have shown abnormal acti-
vation of the PFC in schizophrenic patients under cogni-
tive challenge [8–13]. Moreover, clinical response to cloza-
pine, an atypical antipsychotic drug, was inversely related to
prefrontal atrophy [14]. These studies suggest strongly that
pathophysiology of schizophrenia involves abnormal PFC
neural activity.
Amphetamine (AMP) or methamphetamine (MA) ad-
ministration has been widely used to generate an animal
model of schizophrenia [15]. AMP/MA is known to induce
psychosis in normal human subjects and, if administered to
schizophrenic patients, worsen positive schizophrenic symp-
toms [16–19]. AMP/MA facilitates the release and blocks the
reuptake of dopamine, thus augments synaptic actions of
dopamine [20]. In this respect, AMP/MA model is especially
useful for investigating the role of dopamine hyperactivity in
schizophrenia. Considering its widespread use, it would be
important to understand AMP/MA-induced neural activity
changes in the brain areas that are likely to play important
roles in schizophrenia. To our knowledge, however, neural
activity in the PFC has not been examined in intact animals
following systemic injection of AMP/MA.
In this study, we investigated eﬀects of systemic MA in-
jection on neuronal activity in the medial PFC (mPFC) of
urethane-anesthetized and awake rats. Our results show that
MA injection changes mPFC unit activity in at least two dif-
ferent stages and in an unpredictable manner.
2. EXPERIMENTAL PROCEDURES
2.1. Subjects
Sixty-six young male Sprague-Dawley rats (260–310g, ∼3
months old) were used in this study. Twenty-two and 44 ani-
mals were used for single unit recordings in anesthetized and
awake animals, respectively. All subjects were maintained on
a 12-hour light-dark cycle and allowed to freely access food
and water. The experimental protocol was approved by the2 Neural Plasticity
Ethics Review Committees for Animal Experimentation of
Ajou University School of Medicine, South Korea.
2.2. Unitrecording
2.2.1. Anesthetizedrats
Experimental procedures for unit recording in anesthetized
a n i m a l sh a v eb e e nr e p o r t e dp r e v i o u s l y[ 21]. Brieﬂy, animals
were deeply anesthetized with urethane (1g/kg) and one or
two tetrodes were lowered into the mPFC (2.7mm A and
0.6–1.3mmL to bregma, 2.7–3.3mmV from the brain sur-
face) at an angle of 10◦ toward the midline following cran-
iotomy and removal of dura. Two stainless steel screws were
implanted in the skull for ground and reference leads. Unit
signals from the tetrode were recorded via an FET source-
follower headstage. Output signals from the headstage were
ampliﬁed 10000X, ﬁltered between 0.6–6KHz and digitized
at25KHz.Whenatleastonewell-isolatedandstableunitsig-
nal was obtained, baseline discharges were recorded for 10–
20 minutes and unit signals were recorded 60 more minutes
after injecting (IP) MA (4mg/kg; Sigma, Mo, USA) or ve-
hicle (0.9% saline). Single units were isolated by examining
two-dimensional projections of the relative amplitude data
recorded from four channels of a tetrode, and manually ap-
plying boundaries to each subjectively identiﬁed unit cluster.
Spike width was also used as an additional feature of spike
waveforms for unit isolation. Only those clusters that were
clearlyseparablefromeachotherandfrombackgroundnoise
throughout the recording session were included in the anal-
ysis.
2.2.2. Awakerats
Unit recordings in awake animals were performed as previ-
ously described [22]. Brieﬂy, rats were deeply anesthetized
withsodiumpentobarbital(50mg/kg)andtwotetrodeswere
implanted (one in each hemisphere) above the mPFC (2.5–
3.0mm A and 0.6–1.3mmL to bregma) at an angle 0–10◦
toward the midline. Six stainless steel screws were implanted
in the skull and two of them were used as ground and refer-
ence leads. The entire implant was encased in dental acrylic.
A f t e rr e c o v e r yf r o ms u r g e r yf o r7d a y s ,r a t sw e r er e p e a t e d l y
placed on a pedestal for 2 days for habituation. Rats were
restful on the pedestal most of the time after habituation.
Unit search and recordings were done on the same pedestal.
When at least one well-isolated and stable unit was obtained,
baseline unit discharges were recorded for 10–20 minutes
and unit signals were recorded 60 more minutes after inject-
ing (IP) MA (4mg/kg) or vehicle (0.9% saline). Unit signals
were recorded as in the anesthetized animals. The presence
of stereotypic behaviors (sniﬃng, head bobbing, and rear-
ing) was noted for each recording session, but they were not
quantiﬁed.Suchbehaviorswereobservedinallrecordingses-
sions without exception. MA was injected up to four times to
the same animals over the span of maximum 15 days.
2.3. Histology
When recording was complete, an electrolytic current (50–
100μA, 10–50s) was applied through one of four tetrode
channels and the animals were perfused with 10% formal
saline.Thebrainwasremoved,leftinformalsalinefor3days,
and transferred to a 10% formal saline/30% sucrose solution
for 3 days until it sank to the bottom. Forty μm coronal sec-
tionswerecutonaslidingmicrotomeandstainedwithcresyl
violet. Tracks and lesion sites were identiﬁed by light micro-
scopic observations.
2.4. Dataanalysis
2.4.1. TransienteffectofMA
Some units showed transient elevation of activity follow-
ing MA injection as shown in Figure 2(a). Transient activity
units were deﬁned as those that elevated their discharge rates
more than 100% over the baseline average within 20 minutes
following MA injection and reduced their ﬁring rates more
than 50% from the peak transient response at 35–45 min-
utes following MA injection. Although transient suppression
of unit activity was also observed in some units following
MA injection, decreased unit discharge was less pronounced
compared to elevated unit discharge (because the range of
unit activity change is narrower) and hence it was sometimes
diﬃcult to discriminate such eﬀect from random ﬂuctuation
of unit activity. We therefore report only transient elevation
of unit activity. The transient eﬀect of MA was quantiﬁed by
generating a time proﬁle of unit activity in 1-minute time
resolution and ﬁnding the maximum ﬁring rate during the
ﬁrst 20-minute time period following MA injection. Then
the maximal ﬁring rate bin was combined with surrounding
four bins (two bins on the left and right) to calculate mean
ﬁringrateduringﬁve-minutetimeperiod,andthisvaluewas
expressed as the percent of the baseline average.
2.4.2. Indexofﬁringratechange
The eﬀect of MA on unit discharge rate was stabilized 30
minutes following its injection (Figure 2). The eﬀect of MA
in the stable phase was measured by comparing mean dis-
chargeratesduringthe10-minuteperiodimmediatelybefore
drug injection (baseline) and (35–45)-minute period follow-
ing drug injection during which unit discharges were stabi-
lized. The degree of ﬁring rate change was assessed using the
following index:
Index of ﬁring rate change (IFRC) =
(Post −Pre)
(Post+Pre)
,( 1 )
where Pre and Post denote mean ﬁring rates of a unit before
(−10–0min) and after (35–45min) MA or vehicle injection,
respectively. The index was then transformed to Fisher’s z for
normalization as follows:
z = 0.5[ln(1+IFRC) −ln(1 −IFRC)]. (2)
2.4.3. Burstﬁring
The degree of burst ﬁring during the baseline period was
quantiﬁed as a physiological index to predict the direction ofJinhwa Jang et al. 3
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Figure 1: Recording sites. Single units were recorded in the prelim-
bic (PL) and infralimbic (IL) cortices.
ﬁringratechangeinducedbyMAinjection.Becauseshortin-
terspike intervals (ISIs) contribute more signiﬁcantly to tem-
poral summation of postsynaptic neurons, only ISIs in the
rangeoftensofmillisecondswereconsideredforburstﬁring.
Based on prior examination of ISI distributions [21], analy-
sisofburstﬁringwasconﬁnedtoISIswithin30milliseconds.
The degree of burst ﬁring was calculated as the proportion
ISIs ≤ 30 milliseconds.
2.4.4. Statisticalanalysis
Nonparametric Wilcoxon signed-rank test, Wilcoxon rank-
sum test, and F-test were used to determine statistical signif-
icance. A P value <.05 was used as the criterion for a signif-
icant statistical diﬀerence. All data are expressed as mean ±
SEM.
3. RESULTS
3.1. Neuronaldatabase
All recording locations were identiﬁed within the prelimbic
and infralimbic cortex (Figure 1). To conﬁne our analysis to
putative principal neurons [22], high-ﬁring rate units (mean
baseline ﬁring rate >10Hz) were excluded from the analysis.
We also excluded those units with mean baseline ﬁring rates
<0.1Hz for reliable estimation of MA eﬀect on ﬁring rate.
Thus a total of 44 units in anesthetized rats and 60 units in
awake rats were subject to analysis. Of these, 33 and 11 units
were recorded from MA- and vehicle-injected anesthetized
rats,respectively,and50and10wererecordedfromMA-and
vehicle-injected awake rats, respectively.
The mean discharge rates of mPFC neurons during the
baseline period were 0.89±0.13 (n = 33) and 0.79±0.28Hz
(n = 11) in MA- and vehicle-injected anesthetized animals,
respectively.Inawakeanimals,theywere3.98±0.39(n = 50)
and 1.19 ± 0.29Hz (n = 10), respectively. The mean base-
line discharge rates were signiﬁcantly diﬀerent between MA-
and vehicle-injected groups in awake animals (Wilcoxon
rank-sum test, P = .001), but not in anesthetized animals
(Wilcoxon rank-sum test, P = .432). Hence, sampling was
biased toward high-ﬁring rate units in MA-injected awake
animals. However, it is unlikely that this bias aﬀected the
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Figure 2: Examples of MA eﬀect on unit activity. These examples
show three basic patterns of unit activity change following MA in-
jection. (a) An example that shows transient elevation of ﬁring rate.
(b) An example that elevated its ﬁring rate without transient eleva-
tion. (c) An example that decreased its ﬁring rate without transient
elevation. The units in (a), (b) were recorded from awake rats and
the unit in (c) was recorded from an anesthetized rat. The arrows
indicate the time of MA injection.
analysis results because there was no signiﬁcant correla-
tion between the mean baseline discharge rates and IFRC (z-
transformed values, MA-, and vehicle-injection data com-
bined; anesthetized animals: n = 44 units, r =− .137, P =
.377; awake animals: n = 60 units, r =− .022, P = .862).
3.2. Typesofunitactivitychange
MA injection inﬂuenced unit activity with two diﬀerent
time courses within the recording period (∼60min follow-
ing MA injection) in both anesthetized and awake rats. A
subset of units elevated their activities in a transient man-
ner (<30min) following MA injection, which was never ob-
served with vehicle injection. The other units did not show
such a transient activity change. In all cases, MA eﬀects were
stabilized at 30 minutes following its injection. When sta-
bilized, units both increased and decreased their discharge
rates compared to the baseline. Figure 2 shows examples of
the three types of unit activity change observed in this study.
Overall changes in unit activity following MA or vehicle in-
jection are summarized in Table 1.4 Neural Plasticity
Table 1: Summary of changes in unit activity following MA or vehicle injection.
Treatment No. of units
Baseline
discharge
rate (Hz)
No. of
transient
activity units
Magnitude of
transient
elevation (% of
baseline)
Discharge
rate after
treatment∗
Variance
of IFRC
∗∗
Anesthetized MA 33 0.89 ±0.13 8 371.8 ±67.2% 1.43 ±0.32 0.841
Vehicle 11 0.79 ±0.28 0 — 0.90 ±0.34 0.019
Awake MA 50 3.98 ±0.39 6 404.2±109.3% 4.29 ±0.76 0.883
Vehicle 10 1.19 ±0.29 0 — 2.31 ±0.84 0.089
∗ Measured at 35–45min following MA or vehicle injection
∗∗ z-transformed value.
3.3. MAeffectinanesthetizedanimals
3.3.1. Transienteffect
Eight out of 33 (24.2%) units in anesthetized rats elevated
their discharge rates in a transient manner following MA
injection. The elevated ﬁring rates reached 168.7–657.5%
(mean = 371.8 ± 67.2%) of the baseline average. Their dis-
c h a r g er a t e sc a m ed o w nt os t a b l el e v e l st h a tw e r eb e l o w
(n = 2) or above (n = 6) the baseline rate at 35–45 minutes
following MA injection.
3.3.2. Stableeffect
The mean ﬁring rates during the baseline and at 35–45 min-
utes following vehicle injection (n = 11 units) were 0.79 ±
0.28 and 0.90 ±0.34Hz, respectively, which did not vary sig-
niﬁcantly (Wilcoxon signed-rank test, P = .147). The ﬁr-
ing rates during the baseline and 35–45 minutes following
MA injection were 0.89 ± 0.13 and 1.43 ± 0.32Hz, respec-
tively, which did not vary signiﬁcantly either (n = 33 units,
Wilcoxon signed-rank test, P = .231). Thus, on average, ve-
hicle or MA injection did not increase or decrease ﬁring rate
of mPFC units in a signiﬁcant manner in anesthetized an-
imals. As shown in Figures 2 and 3, however, many mPFC
neurons changed their ﬁring rates in large degrees, albeit
in both directions, following MA injection, whereas vehi-
cle injection induced much smaller changes in ﬁring rates.
This raises a possibility that MA injection altered ﬁring rates
of mPFC neurons in both increasing and decreasing direc-
tions, so that the averaged eﬀect was neither excitatory nor
inhibitory. This possibility was examined by comparing the
variance of z-transformed IFRC between MA- and vehicle-
injected groups (Figure 3). All of the z-transformed index
values lied within 3 SD from the mean for both MA- and
vehicle-injection groups, and hence no outlier was excluded
from the analysis. The variances were 0.841 and 0.019 for the
units recorded from MA- and vehicle-injected anesthetized
animals, respectively. Comparison of the variance ratio indi-
cated that the diﬀerence was signiﬁcant (F32,10 = 38.46, P<
0.001), indicating that MA injection induced larger changes
in ﬁring rate.
3.3.3. Relationshipbetweenphysiologicalindex
andﬁringratechange
We examined whether or not the direction of ﬁring rate
change can be predicted from a physiological index. For ex-
ample, the units with high baseline ﬁring rates may tend to
reduce their ﬁring rates following MA injection. The rela-
tionship between baseline ﬁring rate and z-transformed IFRC
is shown in Figure 3(c).T h ec o r r e l a t i o nc o e ﬃcients were
−.0156 (n = 33), which was not signiﬁcant (P = .385).
The relationship between the degree of burst ﬁring and z-
transformed IFRC was not signiﬁcant either (r = .305, P =
0.084; Figure 3(d)). Thus, two physiological indices, baseline
ﬁring rate, and the degree of burst ﬁring, were not signiﬁ-
cantly correlated with the direction of ﬁring rate changes in
anesthetized animals.
We also divided the units into those that elevated and re-
duced their activities following MA injection, and the mean
discharge rate and the degree of burst ﬁring during the base-
line period were compared between the two groups. The
mean baseline discharge rates of the rate-elevated and rate-
reduced units were 0.95±0.21 (n = 18) and 0.88±0.14 (n =
14), respectively, which did not vary signiﬁcantly (Wilcoxon
rank-sum test, P = .582; one unit did not change its ﬁring
rate). The degree of burst ﬁring was 0.11 ± 0.02 (n = 18)
and 0.08 ± 0.02 (n = 14) for rate-elevated and rate-reduced
units, respectively, which did not vary signiﬁcantly either
(Wilcoxon rank-sum test, P = .262). These results further
indicate that two physiological indices, baseline ﬁring rate
and the degree of burst ﬁring, cannot predict the direction
of mPFC unit activity change following MA injection.
3.3.4. Simultaneouslyrecordedunits
To explore the relationship between the recording location
and the direction of ﬁring rate change, we examined whether
or not units that were recorded with the same tetrode show
consistent changes in ﬁring rate following MA injection. At
least two units (2–4 units) were recorded simultaneously
with the same tetrode in nine anesthetized animals (total 22
units). Of these, ﬁve sessions had mixed directions of ﬁring
rate change and only three had consistent directions of ﬁring
ratechange(intheremainingonerecordingsession,oneunit
decreaseditsﬁringrateandtheotherdidnotchangeitsﬁring
rate).Hence,manysimultaneouslyrecordedneuronsshowedJinhwa Jang et al. 5
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Figure 3: MA eﬀects in anesthetized animals. (a)-(b) The frequency histograms show the distribution of IFRC (z-transformed values) follow-
ing MA (a) or vehicle (b) injection. Positive (or negative) numbers along the abscissa denote enhanced (or reduced) discharge rate following
MAinjection.(c)-(d)TherelationshipbetweenIFRC (z-transformed)andaverageﬁringrate(c)orburstﬁring(d)duringthebaselineperiod.
The lines were obtained by linear regression. None were signiﬁcant.
opposite directions of ﬁring rate change following MA injec-
tion,indicatingthatthedirectionofﬁringratechangecannot
be predicted from the recording location.
3.4. MAeffectinawakeanimals
3.4.1. Transienteffect
Six out of 50 (12%) units transiently elevated their ﬁring
rates following MA injection. The units elevated their ﬁring
rates up to 169.0–1125.1% (mean = 404.2 ± 109.3%) of the
baseline average. The ﬁring rates reduced to stable levels that
were below (n = 5) or above (n = 1) the baseline discharge
rate at 35–45 minutes following MA injection.
3.4.2. Stableeffect
The mean ﬁring rates during the baseline and at 35–45 min-
utes following vehicle injection were 1.19 ± 0.29 and 2.31 ±
0.84Hz,respectively,whichdidnotvarysigniﬁcantly(n = 10
units, Wilcoxon signed-rank test, P = .131). Those following
MA injections were 3.98 ± 0.39 and 4.29 ± 0.76Hz, respec-
tively, which did not vary signiﬁcantly either (n = 50 units,
Wilcoxon signed-rank test, P = .449). However, the vari-
ances of IFRC (z-transformed) were signiﬁcantly diﬀerent be-
tween MA-injected (0.883) and vehicle-injected (0.089) an-
imals (all data lied within 3 SD from the mean for both
groups, F49,9 = 9.95, P<0.001, Figure 4). Thus, as in the
anesthetized animals, MA injection induced larger changes
in unit ﬁring rate in the awake animals compared to vehi-
cle injection. In awake animals, MA was injected up to four
times to the same animals. However, there was no signiﬁ-
cant correlation between the number of MA injections and
z-transformed IFRC (linear regression analysis, r =− .205,
P = .169).
3.4.3. Relationshipbetweenphysiologicalindex
andﬁringratechange
No signiﬁcant relationship was found between the baseline
ﬁring rate and z-transformed IFRC (n = 50, r = .055,
P = .706; Figure 4(c)) or between the degree of burst ﬁring
and z-transformed IFRC (n = 50, r =− .091, P = .529;6 Neural Plasticity
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Figure 4: MA eﬀects in awake animals. (a)-(b) IFRC frequency histograms following MA or vehicle administration. (c)-(d) Relationships
between the index of ﬁring rate change and physiological indices. None were signiﬁcant. The format is as in Figure 3.
Figure 4(d)). The mean baseline ﬁring rates of the rate-
elevated (i.e., positive IFRC, n = 22) and rate-reduced (i.e.,
negative IFRC, n = 28) units were 3.48 ± 0.57 and 4.38 ±
0.53, respectively, which did not vary signiﬁcantly (Wilcoxon
rank-sum test, P = .287). The degree of burst ﬁring was
0.11 ± 0.02 and 0.14 ± 0.02 for the rate-elevated and rate-
reduced units, respectively, which did not vary signiﬁcantly
either (Wilcoxon rank-sum test, P = .287). These results in-
dicate that, as in the anesthetized animals, two physiologi-
cal indices, baseline ﬁring rate and the degree of burst ﬁring,
cannot predict the direction of mPFC unit activity change
following MA injection in awake animals.
3.4.4. Simultaneouslyrecordedunits
In awake animals, of a total of eight recording sessions with
the minimum of two simultaneously recorded units from
the same tetrode (2-3 units, total of 17 units), six showed
mixed directions and only two showed consistent directions
of ﬁring rate change. Hence, as in the anesthetized animals,
many simultaneously recorded neurons showed opposite di-
rections of ﬁring rate change following MA injection, indi-
cating that the direction of ﬁring rate change is poorly pre-
dicted by the recording location.
4. DISCUSSION
The PFC is the major target of mesocortical dopaminergic
projections,andasystemicMAinjectionenhancesdopamine
level in the rat PFC, albeit in a smaller degree compared with
AMP injection [23]. Eﬀects of dopamine on neural activity
in the PFC have previously been examined both in vitro and
in vivo. The results are not consistent, however. Both excita-
tory and inhibitory eﬀects of dopamine have been reported
[24]. It is now clear that the eﬀect of dopamine is not sim-
ply excitatory or inhibitory, but should be understood in the
context of its interactions with other input signals, especially
with glutamatergic signals [24–26]. In this respect, full char-
acterization of PFC neural activity in the AMP/MA model of
schizophrenia would require unit recording in the context of
a wide range of behaviors, especially those that require the
intact PFC. As a ﬁrst step toward this line of investigation, we
recorded unit activity in the mPFC following systemic injec-
tionofarelativelyhighdose(4mg/kg)ofMAinanesthetized
rats and awake rats that were placed on a small pedestal.Jinhwa Jang et al. 7
TheresultsshowthatsystemicadministrationofMAinduces
bidirectionalchangesinunitactivitywithasubsetofneurons
elevating their activities in a transient manner. The direction
of ﬁring rate change could not be predicted based on two
diﬀerent physiological indices or recording locations. Hence,
consistent with previous studies, MA injection was not sim-
ply excitatory or inhibitory to mPFC neurons. Similar results
were obtained across urethane-anesthetized and awake ani-
mals indicating that the observed MA eﬀects cannot be at-
tributed to behavioral feedback.
It is likely that the observed changes in unit activity are
the outcome of both local changes in dopamine concentra-
tion and indirect eﬀects of MA on neural activity in other
brain areas. For example, changes in neural activity in a
structure along the cortico-basal ganglia loop [27–29], such
as the striatum [26], will likely inﬂuence neuronal activity in
thePFC.Inthisregard,arecentstudyhasreportedthatselec-
tive over-expression of D2 receptors in the striatum induced
various changes in the mPFC and working memory deﬁcits
[30]. At present, the relative contributions from the two fac-
tors (dopamine action in the mPFC and changes in aﬀerent
neural activity) are unknown. To delineate the two eﬀects,
studies employing local inactivation of connected brain ar-
eas or local infusion of MA into the mPFC are needed.
Our results show that mPFC units undergo at least two
temporally distinct activity changes following MA injection.
The ﬁrst stage is short lasting (<30min) during which a sub-
set of neurons elevates ﬁring rate in a transient manner. The
second stage is longer lasting (>60min) during which units
both enhance and reduce their ﬁring rates. The two diﬀer-
ent time courses of MA eﬀect may reﬂect the rapid time
course of MA pharmacokinetics. In rats, following IV injec-
tion, plasma MA concentration peaks in ∼30 minutes and
decaysbacktothebaselinelevelwiththeeliminationhalf-life
(t1/2)of∼70minutes(t1/2 is ∼12hoursinhumans)[31].This
may lead to relatively rapid changes in dopamine concentra-
tion in the brain so that multiple time courses of unit activity
changeemergewithinanhourofMAinjection.Alternatively,
transient and stable eﬀects of MA may be mediated by dis-
tinct biochemical processes that have diﬀerent reaction time
courses. A previous study has shown that bath application of
dopamine induces initial depression followed by late activa-
tionofIPSPsinPFCslicesinvitro,whicharemediatedbyD2
and D1 receptor subtypes, respectively [32]. The time course
of IPSP suppression was similar to that of the transient ele-
vation of unit activity observed in the present study. Because
decreased inhibition will lead to enhanced discharge of prin-
cipal neurons, this study suggests that D2 and D1 receptor
activations may underlie transient and stable eﬀects of MA
observed in the present study.
The present results raise the possibility that a high dose
of MA induces practically random changes in ﬁring rate of
mPFCneurons. Wedo notsuggestthatagivenneuron, when
all other factors remain the same, reacts to MA injection in
a stochastic manner. Rather, we raise a possibility that the
direction of ﬁring rate change may be independent on the
functional role played by a given mPFC neuron. Consider-
ing massive associational connections within the neocortex
[33],theﬁnaleﬀectofincreaseddopamineonagivenneuron
is probably an outcome of complicated interactions among
highly interconnected neurons. It is conceivable that a given
neuron may reverse it response to MA injection by a slight
adjustment of its connectivity with other neurons. Various
projection pathways in the PFC indeed support long-term
synaptic plasticity [33–40]. Moreover, dopamine eﬀect on
PFC neurons typically has an inverted-U curve shape [41],
and MA injection induces inconsistent ﬁring rate changes in
other brain structures, such as the striatum, that project to
the mPFC [26]. Combined, from the functional standpoint,
the ﬁnal outcome of over-availability of dopamine may be
random changes in PFC neural activity, which may underlie
some of MA-induced psychotic symptoms. We cannot rule
out the possibility, however, of an unknown relationship be-
tweenthefunctionalroleofaneuronanditsresponsetoMA.
It is also possible that there exist unknown physiological fac-
tors that can predict a neuron’s response to MA injection.
Several issues remain outstanding. First, unit recording
in behaving rats performing a PFC-demanding task, such
as a delayed response task, is required in the future to fully
assess the eﬀect of MA injection. Second, because MA ef-
fects on PFC unit activity are likely to vary according to
the amount of injected MA [41], testing diﬀerent doses of
MA is needed. Third, the present results should be com-
pared with the eﬀects of chronic MA injection. Although
AMP/MA can induce psychosis at the ﬁrst exposure [42, 43],
psychosis is more likely to develop with repeated administra-
tions [15, 44, 45], and chronic administrations of AMP/MA
are generally used as an animal model of schizophrenia
[15, 46]. The majority of units were recorded with the ﬁrst or
thesecondMAinjectioninthepresentstudy,withthelargest
number of injections being only four. Chronic eﬀect of MA
injection could be diﬀerent from what we observed in this
study, which remains to be determined.
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